Extendicare Market Cap

Extendicare has a market cap or net worth of $1.35 billion as of December 5, 2025. Its market cap has increased by 118.33% in one year.

Market Cap

1.35B

Enterprise Value

1.47B

Revenue

1.14B

Ranking

n/a

PE Ratio

20.66

Stock Price

$16.12

Market Cap Chart

Since May 15, 1997, Extendicare's market cap has increased from 973.52M to 1.35B, an increase of 38.68%. That is a compound annual growth rate of 1.15%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	1.35B	118.94%
Dec 31, 2024	616.65M	33.95%
Dec 29, 2023	460.35M	11.06%
Dec 30, 2022	414.49M	-19.77%
Dec 31, 2021	516.64M	10.73%
Dec 31, 2020	466.60M	-19.54%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	561.91M
Glass House Brands	513.14M
CytoDyn	403.93M
American Oncology Network	365.47M
Northwest Biotherapeutics	363.73M
Silence Therapeutics	328.75M
Nika Pharmaceuticals	259.91M

Market Cap Rankings